Insight Molecular Diagnostics Inc. Due to Related Parties, Current
Insight Molecular Diagnostics Inc. (IMDX) had Due to Related Parties, Current of $6.00 thousand as of 2019-12-31, per its 10-K filed 2021-03-19.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2021-03-19
- 2019-12-31: Due to Related Parties, Current $6.00K.
- 2019-06-30: Due to Related Parties, Current $5.00K.
- 2018-12-31: Due to Related Parties, Current $2.10M.
- 2018-09-30: Due to Related Parties, Current $2.11M.
| Period end | Due to Related Parties, Current | Due to Related Parties, Current as first filed |
|---|---|---|
| 2019-12-31 | $6.00K 10-K · filed 2021-03-19 | |
| 2019-06-30 | $5.00K 10-Q · filed 2019-08-14 | |
| 2018-12-31 | $2.10M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $2.11M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $2.10M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.10M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.10M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $2.10M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $2.54M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $2.61M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $2.85M 10-K · filed 2018-04-02 | $2.70M 10-K · filed 2017-02-27 |
| 2016-09-30 | $2.10M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.69M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.32M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $807.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |